Discovery could improve transdermal drug delivery

Related tags Transdermal drug delivery Route of administration Pharmacology

A group of US researchers claim to have identified a fundamental
mechanism that may facilitate the design of safer and more
efficacious topical drug delivery systems, reports Phil

In a paper published in the Proceedings of the National Academy of Sciences, the team, led by Samir Mitragotri, a professor of chemical engineering at the University of California, Santa Barbara, describe how molecules, called chemical penetration enhancers (CPEs) help drugs absorb through the skin.

After analysing more than 100 different CPEs to better understand how they manage to increase skin permeability, the researchers engineered more than 300 new CPEs from the ground up. The design was based on the researchers' understanding of the molecular forces that are associated with CPE safety and potency.

They then screened the new CPEs, first using computer technology and then testing the most promising ones in the laboratory environment. The molecules identified broaden the number of CPEs that can be used in the design of transdermal, cosmetic and pharmaceutical products.

"The methods used in this research not only increase our ability to create effective new CPEs, but they also will expand our ability to evaluate potential new CPEs for safety and efficacy,"​ said Mitragotri.

"By enhancing our ability to deliver drugs topically, we will be able to reduce the number of drugs that must be given by injection."​ Interest in non-injectable routes is one of the key drivers behind the development of transdermal drug delivery, which represented a market of $8 billion in 2002 and is expected to increase to $16.3 billion in 2007.

The skin is composed of several layers. The top layer, or stratum corneum (SC) is made of dead cells that contain proteins and lipid molecules which are arranged in bi-layers. The SC is a significant barrier to the absorption of drug molecules across the skin. CPEs help drug molecules penetrate into the skin by changing the structure of the SC.

Different CPEs penetrate the skin in unique ways. For example, some make microscopic holes in the SC by removing lipids. Others insert themselves in already-crowded lipid bi-layers to disorganise them. Some can also break open the dead cells in the SC and interact with the protein in those cells. CPEs that cause skin irritation are typically associated with the unfolding of proteins in skin cells.

By studying the molecular properties of a CPE, its propensity to penetrate or irritate the skin can be predicted. Simply put, the researchers draw a CPE's structure on a computer, input its molecular properties, and then compute its penetrability or effectiveness and its potential to irritate the skin.

Such computer-aided modeling facilitates the analysis of millions of molecules, allowing researchers to then submit the most promising candidates to further in vivo​ laboratory analysis.

Related topics Ingredients Delivery technologies

Related news

Show more

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more